Novartis Kisqali® delivers consistently superior overall survival – MONALEESA-3 trial demonstrates more life for postmenopausal HR+/HER2- advanced breast cancer patients

Matthew Durham
Omnidynamic Marketing

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Bud Bilanich
Success Coach

Matt Turner
Patient Affordability

Paul Theisen
Patient Acquisition

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling